Since 1967, Fermilab has worked to answer these and other fundamental questions and enhance our understanding of everything we see around us. As the United States' premier particle physics laboratory, we work on the world's most advanced particle accelerators and dig down to the smallest building blocks of matter.
So, survival rate and life expectancy for stage 4 prostate cancer cannot be favorable. âº The five-year relative survival rate for prostate cancer that has spread to distant organs is 28%. This means about 28% of the patients with stage 4 prostate cancer will live for five years.
In a second single institutional series of 400 patients with stages I through IVb tonsillar cancer, of whom 140 underwent planned neck dissection (130 unilateral, 10 bilateral), the five year local control rates for T1-T4 disease were 83, 81, 74, and 60 percent The five-year cause-specific survival rates by stage were:tage I 65 percent Stage II 54 percent Stage III 44 percent Stage IV 30 percent. For patients with stage I and II cancers, survival rates appeared to be highest for patients treated with surgery alone, followed by surgery plus radiotherapy, and finally radiotherapy alone (75, 63, and 46 percent, respectively).